Added to YB: 2025-06-13
Pitch date: 2025-06-10
PAX.ST [neutral]
Paxman AB (publ)
-33.09%
current return
Author Info
Long-Term Pick shares in-depth stock analysis on high-quality stocks with growth potential. Sign up for the newsletter.
Company Info
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide.
Market Cap
SEK 1.8B
Pitch Price
SEK 82.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.63
P/E
73.73
EV/Sales
5.98
Sector
Health Care Equipment and Supplies
Category
growth
Paxman: Medical Scalp Cooling Systems Leader
PAX.ST (overview): Swedish medical device leader in scalp cooling for chemo hair loss. Q1'25: SEK 67.1M sales (+14.5% YoY). CPT codes effective 2026 enable insurance billing. Acquired competitor Dignitana in 2025. $1.5B market growing at 11.43% CAGR to 2033. Launching cryocompression system in 2026. Currency risk & margin pressure are concerns.
Read full article (7 min)